Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
11/2014
11/04/2014US8877176 Methods for promoting wound healing and muscle regeneration with the cell signaling protein Nell1
11/04/2014US8877175 Long lasting drug formulations
11/04/2014US8877172 Zwitterionic polymer bioconjugates and related methods
11/04/2014US8877161 GM1-like peptides and uses thereof
11/04/2014US8877158 Targeting agent to newly formed blood vessels
11/04/2014US8875970 Structure containing wound treatment material
10/2014
10/30/2014US20140325691 Regulation of endogenous gene expression in cells using zinc finger proteins
10/30/2014US20140323924 Targeted optogenetic neuromodulation for treatment of clinical conditions
10/30/2014US20140323706 Nucleic acids encoding receptor for il-17 homologous polypeptides and uses thereof
10/30/2014US20140323690 Antiproliferative compounds, conjugates thereof, methods therefor, and uses thereof
10/30/2014US20140323574 Infant formula with high sn-2 palmitate and oligofructose
10/30/2014US20140323415 Organic compounds
10/30/2014US20140323413 Methods of diagnosing and treating vascular associated maculopathy and symptoms thereof
10/30/2014US20140323410 Use of hdl-related molecules to treat and prevent proinflammatory conditions
10/30/2014US20140323409 Apotransferrin for the treatment of brain stroke
10/30/2014US20140323406 Method and compositions for treating stroke with fever
10/30/2014US20140323402 Protein Carrier-Linked Prodrugs
10/30/2014US20140323399 Compositions and methods for increasing insulin sensitivity
10/30/2014US20140323395 Methods for Treating HCV
10/30/2014US20140323392 Methods and compositions related to inhibition of viral entry
10/30/2014US20140322791 Process to prepare a stable thrombin composition
10/30/2014US20140322756 Method for making multispecific antibodies having heteromultimeric and common components
10/30/2014US20140322368 Method of reducing and improving the appearance of scar tissue
10/30/2014US20140322342 Co-encapsulation of live cells with oxygen-generating particles
10/30/2014US20140322341 Novel hemostatic patch and uses thereof
10/30/2014US20140322336 Sustained-release microspheres and methods of making and using same
10/30/2014US20140322332 Antagonists of muc1
10/30/2014US20140322329 Multipurpose gel for vaginal dryness with direct and delayed effect
10/30/2014US20140322317 Controlled release compositions
10/30/2014US20140322309 Alpha-aminoamidine polymers and uses thereof
10/30/2014US20140322308 Compositions for Preventing or Treating Adverse Reactions of EGFR Inhibition
10/30/2014US20140322307 Peptides which inhibit activated receptors and their use in cosmetic or pharmaceutical compositions
10/30/2014US20140322302 Therapeutic peptides
10/30/2014US20140322290 Methods, compositions and devices utilizing stinging cells/capsules for conditioning a tissue prior to delivery of an active agent
10/30/2014US20140322274 Therapeutic Agents
10/30/2014US20140322242 Materials and methods for the prevention and treatment of cancer
10/30/2014US20140322237 Neurodegenerative diseases and methods of modeling
10/30/2014US20140322232 Methods of administering anti-tnfalpha antibodies
10/30/2014US20140322231 Osteoprotegerin in neuroprotection
10/30/2014US20140322227 Peptides for treatment of bone deficiency and autoimmune disorders
10/30/2014US20140322226 Acth for treatment of acute respiratory distress syndrome
10/30/2014US20140322213 Pharmaceutical Composition for the Treatment of Type-1 Diabetes
10/30/2014US20140322205 Rtef-1 variants and the use thereof for inhibition of angiogenesis
10/30/2014US20140322197 Methods for treatment of hip and groin pain associated with femoroacetabular impingement (fai)
10/30/2014US20140322196 Lactoferrin derived peptides for use as broad-spectrum inhibitors of influenza virus infection
10/30/2014US20140322194 Methods for preparing Factor X, activated Factor X, inactivated factor X and inactivated factor Xa, and pharmaceutical compositions comprising same
10/30/2014US20140322193 Therapies for Disorders of the Cornea and Conjunctiva
10/30/2014US20140322192 Proteoglycan degrading mutants for treatment of cns
10/30/2014US20140322190 Pharmaceutical Compositions and Methods for Digesting Atherosclerotic Plaques
10/30/2014US20140322165 Inhibitors of hepatitis c virus polymerase
10/30/2014US20140322162 Use of Ferritin to Treat Iron Disorders
10/30/2014US20140322161 Anti-il-6 vaccine composition
10/30/2014US20140322160 Method and composition for altering a b cell mediated pathology
10/30/2014US20140322158 Methods of treating a subject afflicted with an autoimmune disease using predictive biomarkers of clinical response to glatiramer acetate therapy in multiple sclerosis
10/30/2014US20140322136 Methods for treating obesity
10/30/2014US20140322134 Treatment and Imaging Methods Using Antibodies to Aminophospholipids
10/30/2014US20140322129 Anti-b7-h4 antibodies and immunoconjugates
10/28/2014US8874204 Implantable medical devices comprising isolated extracellular matrix
10/28/2014US8871995 Method for screening an agent being useful for the treatment of dry eye and/or corneal and conjunctival lesion and pharmaceutical composition obtained by the method
10/28/2014US8871915 Peptides targeting TNF family receptors and antagonizing TNF action, compositions, methods and uses thereof
10/28/2014US8871907 Glycosylated immunoglobulin and immunoadhesin comprising the same
10/28/2014US8871906 Deletions in domain II of pseudomonas exotoxin a that remove immunogenic epitopes
10/28/2014US8871905 Modification of CXCR4 using engineered zinc finger proteins
10/28/2014US8871904 Processes and intermediates
10/28/2014US8871901 Phage constructs, sequences and antigenic compositions for immunocontraception of animals
10/28/2014US8871900 Fibroblast growth factor (FGF) analogs and uses thereof
10/28/2014US8871899 Control of viral-host membrane fusion with hydrogen bond surrogate-based artificial helices
10/28/2014US8871818 Gastrointestinal absorption enhancer mediated by proton-coupled transporter and its preparing method
10/28/2014US8871812 Therapeutic regimen comprising PEG-interferon, ribavirin and VX-950 for the treatment of hepatitis
10/28/2014US8871763 Use and application of a pharmaceutical composition containing a mixture of natural-origin heterocyclical guanidine, for cosmetology, wound healing, focal dystonia and muscular spasm- related clinical pathologies
10/28/2014US8871742 Composition and method for treating connective tissue damage
10/28/2014US8871733 Treating glaucoma, cardiovascular diseases, and renal diseases
10/28/2014US8871725 Pharmaceutical combination for the treatment and/or chemosensibilization of refractory tumors to anticancer drugs
10/28/2014US8871724 Oligopeptidic compounds and uses thereof
10/28/2014US8871723 Glycan modified soluble receptors and binding protein and their use
10/28/2014US8871722 Perhydrolase epitopes
10/28/2014US8871721 Methods for inhibiting peritoneal dissemination of cancer cells
10/28/2014US8871720 Monomethylvaline compounds having phenylalanine carboxy modifications at the C-terminus
10/28/2014US8871719 Modified MELK peptides and vaccines containing the same
10/28/2014US8871718 Transglutaminase inhibitors and methods of use thereof
10/28/2014US8871717 Personal care compositions
10/28/2014US8871716 Use of antimicrobial peptides in regeneration of skin cells
10/28/2014US8871714 Hyperglycosylated human coagulation factor IX
10/28/2014US8871713 Formulations of growth hormone releasing factor (GRF) molecules with improved stability
10/28/2014US8871712 Somatostatin analogue formulations
10/28/2014US8871711 Fibroblast growth factor-9 promotes hair follicle regeneration after wounding
10/28/2014US8871710 Method for inducing tissue growth, differentiation and/or regeneration by delivering a GDF-5 related precursor protein
10/28/2014US8871709 Synthetic chimeric proteins comprising epidermal growth factor and vitronectin
10/28/2014US8871708 Compositions and methods for treating AIDS or cancer by inhibiting the secretion of microparticles
10/28/2014US8871707 Elastin producing fibroblast formulations and methods of using the same
10/28/2014US8871706 Method for inhibiting inflammation and pre-inflammatory cytokine/chemokine expression using a ghrelin analogue
10/28/2014US8871468 Synthetic genes for plant gums and other hydroxyproline-rich glycoproteins
10/28/2014US8871456 Probe incorporation mediated by enzymes
10/28/2014US8871445 CRISPR-Cas component systems, methods and compositions for sequence manipulation
10/28/2014US8871267 Protein matrix materials, devices and methods of making and using thereof
10/28/2014US8871257 Prevention and treatment of cardiovascular diseases using systems and methods for transdermal nitric oxide delivery
10/28/2014US8871251 Liposome and method for producing the same
10/28/2014US8871250 Method of treating patients with a mucinous glycoprotein (MUC-1) vaccine
10/28/2014US8871224 Botulinum toxin therapy for skin disorders
10/28/2014US8871221 Methods of stimulating protective immunity employing Dengue viral antigens
1 ... 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 ... 3163